This Management's Discussion and Analysis of Financial Condition and Results of
Operations section should be read in conjunction with the unaudited condensed
consolidated financial statements and notes thereto included elsewhere in this
Quarterly Report on Form 10-Q. This discussion and analysis contains
forward-looking statements, such as statements of our plans, objectives,
expectations and intentions. Any statements that are not statements of
historical fact are forward-looking statements. When used, the words "believe,"
"plan," "intend," "anticipate," "target," "estimate," "expect," "will,"
"continue," "project," and the like, and/or future tense or conditional
constructions ("will," "may," "could," "should," etc.), or similar expressions,
identify certain of these forward-looking statements. These forward-looking
statements are subject to risks and uncertainties, including those we describe
under "Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q that
could cause actual results or events to differ materially from those expressed
or implied by the forward-looking statements. Our actual results and the timing
of events could differ materially from those anticipated in these
forward-looking statements as a result of a variety of factors.

For purposes of this discussion, "Rigetti," "the Company," "we," "us" or "our" refer to Rigetti Computing, Inc. and its subsidiaries unless the context otherwise requires.

Restatement of Previously Issued Financial Statements



As discussed in Note 1, Restatement of Condensed Consolidated Financial
Statements and Immaterial Correction of Prior-Period Errors, to the unaudited
condensed consolidated financial statements included elsewhere in this Quarterly
Report on Form 10-Q, we are restating our consolidated financial statements and
related financial information for the quarters ended March 31, 2022 and June 30,
2022.

Overview

On March 2, 2022 (the "Closing Date"), we consummated the transactions
contemplated by that certain Agreement and Plan of Merger dated as of October 6,
2021, as amended on December 23, 2021 and January 10, 2022 (as amended, the
"Merger Agreement"), by and among Supernova Partners Acquisition Company II,
Ltd., a Cayman Islands exempted company ("Supernova"), Supernova Merger Sub,
Inc., a Delaware corporation and a direct wholly owned subsidiary of Supernova
(the "First Merger Sub"), Supernova Romeo Merger Sub, LLC, a Delaware limited
liability company and a direct wholly owned subsidiary of Supernova (the "Second
Merger Sub"), and Rigetti Holdings, Inc., a Delaware corporation ("Legacy
Rigetti"). As contemplated by the Merger Agreement, on March 1, 2022 Supernova
was domesticated as a Delaware corporation and changed its name to "Rigetti
Computing, Inc." (the "Domestication"). On the Closing Date, (i) First Merger
Sub merged with and into Legacy Rigetti, the separate corporate existence of
First Merger Sub ceased and Legacy Rigetti survived as a wholly owned subsidiary
of Rigetti Computing, Inc. (the "Surviving Corporation" and, such merger, the
"First Merger"), and (ii) immediately following the First Merger, the Surviving
Corporation merged with and into the Second Merger Sub, the separate corporate
existence of the Surviving Corporation ceased and Second Merger Sub survived as
a wholly owned subsidiary of Rigetti Computing, Inc. and changed its name to
"Rigetti Intermediate LLC" (such merger transaction, the "Second Merger" and,
together with the First Merger, the "Merger", and, collectively with the
Domestication, the "PIPE Financing" (as defined below) and the other
transactions contemplated by the Merger Agreement, the "Business Combination").
The closing of the Business Combination is herein referred to as "the Closing."

We build quantum computers and the superconducting quantum processors that power
them. We believe quantum computing represents one of the most transformative
emerging capabilities in the world today. By leveraging quantum mechanics, we
believe our quantum computers process information in fundamentally new, more
powerful ways than classical computers. When scaled, it is anticipated that
these systems will be poised to solve problems of staggering computational
complexity at unprecedented speed.

                                       42

--------------------------------------------------------------------------------

Table of Contents



With the goal of unlocking this opportunity, we have developed the world's first
multi-chip quantum processor for scalable quantum computing systems. We believe
that this patented and patent pending, modular chip architecture is the building
block for new generations of quantum processors that we expect to achieve a
clear advantage over classical computers.

Our long-term business model centers on revenue generated from quantum computing
systems made accessible via the cloud in the form of Quantum Computing as a
Service ("QCaaS") products. However, the substantial majority of our revenues is
derived from development contracts, and we anticipate this to persist over at
least the next several years as we work to ramp up our QCaaS business.
Additionally, we are working to further develop a revenue stream and forging
important customer relationships by entering into technology development
contracts with various partners.

We are a vertically integrated company. We own and operate Fab-1, a dedicated
and integrated laboratory and manufacturing facility, through which we own the
means of producing our breakthrough multi-chip quantum processor technology. We
leverage our chips through a full-stack product development approach, from
quantum chip design and manufacturing through cloud delivery. We believe this
full-stack development approach offers both the fastest and lowest risk path to
building commercially valuable quantum computers.

We have been generating revenue since 2018 through partnerships with government
agencies and commercial organizations; however, we have not yet generated
profits. We have incurred significant operating losses since inception. Our net
losses were $18.8 million and $9.8 million for the three months ended
September 30, 2022 and September 30, 2021, respectively, and $48.6 million and
$27.6 million for the nine months ended September 30, 2022 and September 30,2021
respectively. As we expect to continue to invest in research and development
infrastructure, we expect to continue to incur additional losses for the
foreseeable future in line with our long-term business strategy. As of
September 30, 2022, we had an accumulated deficit of $255.8 million.

The Business Combination and PIPE Financing



On October 6, 2021, SNII entered into the Merger Agreement by and among
Supernova, First Merger Sub, Second Merger Sub, and Legacy Rigetti. On March 2,
2022, the Business Combination was consummated. While the legal acquirer in the
Merger Agreement was Supernova, for financial accounting and reporting purposes
under United States generally accepted accounting principles ("U.S. GAAP"),
Rigetti was the accounting acquirer and the Merger was accounted for as a
"reverse recapitalization." A reverse recapitalization does not result in a new
basis of accounting, and financial statements of Rigetti represent the
continuation of the financial statements of Legacy Rigetti in many respects.
Under this method of accounting, Supernova was treated as the "acquired" company
for financial reporting purposes. For accounting purposes, Rigetti was deemed to
be the accounting acquirer in the transaction and, consequently, the transaction
was treated as a recapitalization of Rigetti (i.e., a capital transaction
involving the issuance of stock by Supernova for the stock of Rigetti).

As a result of the Business Combination, all of the shares of Legacy Rigetti
Common Stock outstanding immediately prior to the Closing (including Legacy
Rigetti Common Stock resulting from the Legacy Rigetti preferred stock
conversion) were converted into the right to receive an aggregate of 78,959,579
shares of our Common Stock, par value $0.0001 per share ("Common Stock").
Additionally, each issued and outstanding share of Supernova Class A and Class B
Common Stock held by Supernova automatically converted to 20,209,462 shares of
Common Stock (of which 3,059,273 shares are subject to vesting under certain
conditions). Upon consummation of the Business Combination, the most significant
change in our reported financial position and results of operations was an
increase in cash of $205.0 million (as compared to Rigetti's balance sheet at
December 31, 2021), including $225.6 million of proceeds from the Business
Combination and PIPE Financing net against transaction costs incurred by us of
$20.65 million.

Additional direct and incremental transaction costs were also incurred by
Rigetti in connection with the Business Combination. Generally, costs (e.g.,
SPAC shares) are recorded as a reduction to additional paid-in capital. Costs
allocated to liability-classified instruments that are subsequently measured at
fair value through earnings (e.g., certain SPAC warrants) are expensed.
Rigetti's transaction costs totaled $20.65 million, of which $19.75 million was
allocated to equity-classified instruments and recorded as a reduction to
additional paid-in capital, and the remaining $0.9 million was allocated to
liability-classified instruments that are subsequently measured at fair value
through earnings and recognized as expense in the condensed consolidated
statements of operations during the nine months ended September 30, 2022.

As a result of the Business Combination, we became subject to the reporting
requirements under the Securities Exchange Act of 1934, as amended, and listing
standards of the Nasdaq Capital Market, which will necessitate us to hire
additional personnel and implement procedures and processes to address such
public company requirements. We expect to incur additional ongoing expenses as a
public company for, among other things, directors' and officers' liability
insurance, director fees, and additional internal and external accounting, legal
and administrative resources.

                                       43

--------------------------------------------------------------------------------

Table of Contents

Our future results of consolidated operations and financial position may not be comparable to historical results as a result of the Business Combination.

COVID-19 Update and Other Events



The COVID-19 pandemic and impacts resulting therefrom, including with respect to
macroeconomic conditions and supply related issues, continue to evolve and we
intend to continue to monitor it closely.

The evolution of the virus is unpredictable and any resurgence may slow down our
ability to develop our quantum computing products and related services. The
COVID-19 pandemic has limited and could further limit the ability of suppliers
and business partners to perform, including third-party suppliers' ability to
provide components, services and materials. We have experienced and may
experience further increases in the cost of raw materials.

Following the recent invasion of Ukraine by Russia, the U.S. and global
financial markets experienced volatility, which has led to disruptions to trade,
commerce, pricing stability, credit availability, supply chain continuity and
reduced access to liquidity globally. In response to the invasion, the United
States, United Kingdom and European Union, along with others, imposed
significant new sanctions and export controls against Russia, Russian banks and
certain Russian individuals and may implement additional sanctions or take
further punitive actions in the future. The full economic and social impact of
the sanctions imposed on Russia and possible future punitive measures that may
be implemented, as well as the counter measures imposed by Russia, in addition
to the ongoing military conflict between Ukraine and Russia, remains uncertain;
however, both the conflict and related sanctions have resulted and could
continue to result in disruptions to trade, commerce, pricing stability, credit
availability, supply chain continuity and reduced access to liquidity on
acceptable terms, in both Europe and globally, and has introduced significant
uncertainty into global markets. As a result, our business and results of
operations may be adversely affected by the ongoing conflict between Ukraine and
Russia and related sanctions, particularly to the extent it escalates to involve
additional countries, further economic sanctions or wider military conflict.

During the three and nine months ended September 30, 2022, we experienced supply
chain challenges, which we largely attribute to the COVID-19 pandemic and the
general disruptions resulting from the ongoing conflict between Ukraine and
Russia and related sanctions, as well as increases in costs of component parts,
labor and raw materials, which we largely attribute to rising inflation and high
demand as a result of restricted supply. We expect these increased costs to
remain high as the COVID-19 pandemic, the Ukraine-Russia conflict and their
respective effects persist. As global economic conditions recover from the
COVID-19 pandemic, the Ukraine-Russia conflict and the related sanctions,
business activity may not recover as quickly as anticipated, and it is not
possible at this time to estimate the long-term impact that these and related
events could have on our business, as the impact will depend on future
developments, which are highly uncertain and cannot be predicted. For instance,
product demand may be reduced due to an economic recession, a decrease in
corporate capital expenditures, prolonged unemployment, rising inflation and
interest rates, labor shortages, reduction in consumer confidence, adverse
geopolitical and macroeconomic events, or any similar negative economic
condition. In addition, global economic conditions have been worsening, with
disruptions to, and volatility and uncertainty in, the credit and financial
markets in the U.S. and worldwide resulting from the effects of COVID-19 and
increases in inflation and interest rates. If these conditions persist and
deepen, we could experience an inability to access additional capital or our
liquidity could otherwise be impacted. If we are unable to raise capital when
needed or on attractive terms, we would be forced to delay, reduce or eliminate
our research and development programs and other efforts. However, like many
other companies, we are taking actions to monitor our operations to account for
the increases in cost of capital. Specifically, this includes efforts to enhance
our operational efficiency, maximize our R&D spend through strategic
collaborations, and being highly selective in hiring top-tier talent.

Impacts of the COVID-19 pandemic, geopolitical, and macroeconomic conditions,
some of which we have already experienced, include those described throughout
the "Risk Factors" included in this Quarterly Report on Form 10-Q, including the
risk factor titled "We have been, and may in the future be, adversely affected
by the global COVID-19 pandemic, its various strains or future pandemics" and
"Unfavorable conditions in our industry or the global economy, could limit our
ability to grow our business and negatively affect our results of operations."

                                       44

--------------------------------------------------------------------------------

Table of Contents

Change in Fiscal Year



In October 2021, our board of directors approved a change to our fiscal year-end
from January 31 to December 31, effective December 31, 2021. We believe the
year-end change is important and useful to our financial statement users to
allow for increased comparability with our industry peers. As a result of this
change, our fiscal year now begins on January 1 and ends on December 31 of each
year, starting on January 1, 2022. Year-over-year quarterly financial data has
been and will continue to be recast to be comparative with the new fiscal
quarter ends in the new fiscal year.

Key Components of Results of Operations

Revenue



We generate revenue through our development contracts, as well as from our QCaaS
offerings and other services including training and provision of quantum
computing components. Development contracts are generally multi-year,
non-recurring arrangements pursuant to which we provide professional services
regarding collaborative research in practical applications of quantum computing
to technology and business problems within the customer's industry or
organization and assists the customer in developing quantum algorithms and
applications to assist customers in areas of business interest. QCaaS revenue is
recognized on a ratable basis over the contract term or on a usage basis, which
generally ranges from three months to two years. Revenue related to development
contracts and other services is recognized as the related milestones are
completed or over time, as the work required to complete these milestones is
completed. Revenue related to the sale of custom quantum computing components is
recognized at a point in time upon acceptance by the customer.

Cost of Revenue



Cost of revenue consists primarily of all direct and indirect cost associated
with providing QCaaS offerings and development contracts and other services,
including employee salaries and employee related costs, including compensation,
bonuses, employee taxes and benefit costs of program management and personnel
associated with the delivery of goods and services to customers and sub-contract
costs for work performed by third parties. Cost of revenue also includes an
allocation of facility costs, depreciation and amortization directly related to
providing the QCaaS offerings and development contracts and other services. We
expect cost of revenue to increase as we continue to expand on our operations,
enhance our service offerings and expand our customer base.

Operating Expenses

Our operating expenses consist of sales and marketing, general and administrative and research and development expenses.

Research and Development



Research and development costs are expensed as incurred. Research and
development expenses include compensation, employee benefits, stock-based
compensation, outside consultant fees, allocation of facility costs,
depreciation and amortization, materials and components purchased for research
and development. We expect research and development expenses to increase as we
invest in the enhancement of our product offerings. We do not currently
capitalize any research and development expenditures.

Sales and Marketing



Sales and marketing expenses consist primarily of compensation including
stock-based compensation, employee benefits of sales and marketing employees,
outside consultants' fees, travel and marketing and promotion costs. We expect
selling and marketing expenses to increase as we continue to expand on our
operations, enhance our service offerings, expand our customer base, and
implement new marketing strategies.

General and Administrative



General and administrative expenses include compensation, employee benefits,
stock-based compensation, legal, insurance, finance administration and human
resources, an allocation of facility costs (including leases), bad debt costs,
professional service fees, and an allocation of other general overhead costs
including depreciation and amortization to support our operations, which consist
of operations other than associated with providing QCaaS offerings and
development contracts and other services. We expect our general and
administrative expenses to increase as we continue to grow our business. We also
expect to incur additional expenses as a result of operating as a public
company.

                                       45

--------------------------------------------------------------------------------

Table of Contents

Provision for Income Taxes



Income taxes are accounted for under the asset and liability method. Deferred
tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of
existing assets and liabilities and their respective tax bases and operating
loss and tax credit carryforwards. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or
settled. The effect on deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that includes the enactment date. A
valuation allowance is recorded for deferred tax assets if it is more likely
than not that some portion or all of the deferred tax assets will not be
realized. We have recorded a full valuation allowance against our deferred tax
assets.

Results of Operations

Three and Nine Months Ended September 30, 2022 compared to Three and Nine Months Ended September 30, 2021



The following tables set forth our results of operations for the periods
indicated:

                                             Three Months Ended                                                   Nine Months Ended
                                                September 30,               2022 versus 2021                        September 30,                2022 versus 2021
                                             2022           2021         $ Change       % Change                 2022           2021         $ Change        % Change
                                                       ( In thousands)                                                     ( In thousands)
Revenue:                                   $   2,804      $  2,919      $     (115 )           -4 %            $   7,042      $   6,818      $     224               3 %
Cost of revenue                                  776           446             330             74 %                2,063          1,083            980              90 %

Total gross profit                             2,028         2,473            (445 )          -18 %                4,979          5,735           (756 )           -13 %
Operating expenses:
Research and development                      17,365         7,484           9,881            132 %               44,040         21,915         22,125             101 %
Sales and marketing                            1,960           782           1,178            151 %                4,922          1,738          3,184             183 %
General and administrative                    14,027         3,376          10,651            315 %               38,371          8,608         29,763             346 %

Total operating expenses                      33,352        11,642          21,710            186 %               87,333         32,261         55,072             171 %

Loss from operations                         (31,324 )      (9,169 )       (22,155 )          242 %              (82,354 )      (26,526 )      (55,828 )           210 %

Other (expense) income, net:
Interest expense                              (1,436 )        (589 )          (847 )          144 %               (3,811 )       (1,077 )       (2,734 )           254 %
Interest income                                1,042             2           1,040             nm                  1,172              9          1,163              nm
Change in fair value of derivative
warrant liabilities                            8,103            -            8,103             nm                 19,853             -          19,853              nm
Change in fair value of earn-out
liability                                      4,860            -            4,860             nm                 17,418             -          17,418              nm
Transaction cost                                  -             -               -              nm                   (927 )           -            (927 )            nm
Other income                                      -             -               -              nm                     -             (23 )           23            -100 %

Total other income (expense), net             12,569          (587 )        13,156                                33,705         (1,091 )       34,796
Net loss before provision for income
taxes                                        (18,755 )      (9,756 )        (8,999 )                             (48,649 )      (27,617 )      (21,032 )
Provision for income taxes                        -             -               -                                     -              -              -

Net loss                                   $ (18,755 )    $ (9,756 )    $   (8,999 )                           $ (48,649 )    $ (27,617 )    $ (21,032 )



Revenue

Revenue decreased $0.1 million, or 4%, to $2.8 million for the three months
ended September 30, 2022, down from $2.9 million for the three months ended
September 30, 2021. The period over period change is attributable to a decrease
in revenue of $2.0 million due to the completion of phase 1 of two government
revenue contracts prior to July 2022, offset by a total $1.9 million increase in
revenue from commencing phase 2 of a large government agency project of
$0.4 million, a new fiscal year 2022 government agency project of $0.2 million,
QCaaS usage from customers of $1.0 million, and revenue from other projects of
$0.3 million during the three months ended September 30, 2022.

Revenue increased $0.2 million, or 3%, to $7.0 million for the nine months ended
September 30, 2022, up from $6.8 million for the nine months ended September 30,
2021. The period over period increase was primarily attributable to an increase
in revenue of $0.9 million due to the start of two new government contracts,
increase in revenue due to the expansion in scope of one U.S. commercial project
of $0.4 million, increase in revenue for other projects for a total of
$0.1 million, offset by a $0.6 million decrease in revenue related to a U.K.
government agency project in the nine months ended September 30, 2022, and a
$0.7 million decrease in revenue due to the delay in certain anticipated work on
a U.S. government project initially expected to take place in the third quarter
of 2022 and now expected to take place in fiscal year 2023.

These development contracts are fixed price milestone or cost share-based
contracts and the timing and amounts of revenue recognized in each quarter will
therefore vary based on the delivery of the associated milestones and/ or the
work performed. We expect to continue to generate the majority of our revenue
from development contracts over at least the next several years and that revenue
will be variable in timing and size as we work to ramp up our QCaaS business for
the longer term. In addition, as previously disclosed, we are negotiating
contracts with a government entity that is also an existing customer and the
contracting process has

                                       46

--------------------------------------------------------------------------------

Table of Contents



taken longer than anticipated. Accordingly, there is a risk that some of the
$4.0 million revenue we anticipate from these contracts would be deferred to
later fiscal periods after the 2022 fiscal year if the contract negotiations are
not completed, the contracts are not executed and we are unable to invoice for
the full amount in 2022. Moreover, if negotiations result in contract terms that
are less favorable than we anticipated, the total expected value of these
contracts could decrease. Additionally, a portion of such anticipated revenue
relates to work that has already been performed and costs that have already been
incurred. While we have made progress in the negotiation and expect to complete
the negotiation prior to the current fiscal year end, we cannot assure the
execution of these contracts or receipt of payment by the end of the fiscal
year. If the contracts are not ultimately executed, it would likely be very
difficult to realize the expected revenue from this government entity and we may
be unable to recoup all or a portion of costs already incurred.

Cost of Revenue



Cost of revenue increased by $0.3 million, or 74%, to $0.8 million for the three
months ended September 30, 2022, as compared to $0.4 million for the three
months ended September 30, 2021. The increase was mainly attributable to an
increase in subcontractor costs of $0.3 million associated with specific
projects and collaborative development contract services work with government
agencies.

Cost of revenue increased by $1.0 million, or 90%, to $2.1 million for the nine
months ended September 30, 2022, as compared to $1.1 million for the nine months
ended September 30, 2021. The increase was mainly attributable to an increase in
employee-related costs of $0.2 million and subcontractor costs of $0.8 million
associated with specific projects and collaborative development contract
services work with government agencies.

We expect these costs to increase as we expand headcount and increase third
party subcontractor costs related to our collaborative development contract
services work with government agencies. In addition, we have incurred and may
continue to incur increased costs associated with equipment, system components
and labor due to current global economic conditions, including inflation, labor
shortages and supply conditions.

Operating Expenses

Research and Development Expenses

Research and development expenses increased by $9.9 million, or 132%, to $17.4 million for the three months ended September 30, 2022, from $7.5 million for the three months ended September 30, 2021. The increase was primarily attributable to:



     •    a $7.5 million increase in employee related costs in the three months
          ended September 30, 2022, due to an increase in headcount and related
          wage costs of $1.8 million, and a $5.7 million increase in stock

compensation expense which includes annual refresh grants of restricted


          stock to employees of $4.6 million.



     •    a $2.4 million increase associated with the continued and expanded
          investment in research and development efforts, including a $1.5 million
          increase in software subscription and material costs, a $0.4 million

increase in rent and utilities related to expansion of facilities, and a

$0.5 million increase in associated depreciation from increased capital

expenditures.

Research and development expenses increased by $22.1 million, or 101%, to $44.0 million for the nine months ended September 30, 2022, from $21.9 million for the nine months ended September 30, 2021. The increase was primarily attributable to:



     •    a one-time correction during the nine months ended September 30, 2022
          representing estimated electrical utility fees for a portion of the
          electrical usage at our Berkeley facility from February 2019 to
          December 30, 2021, which was an out-of-period adjustment. We have
          cumulatively recorded an accrual of $1.5 million for the three months
          ended March 31, 2022, and an additional $0.1 million to accrue for the

three months ended June 30, 2022. For further detail on these additional

expenses, see Note 1 to our unaudited condensed consolidated financial

statements for the nine-month period ended September 30, 2022 included

elsewhere in this Quarterly Report on Form 10-Q. The actual amount of

fees that we may be required to pay to our electricity provider and any

related costs, expenses or penalties may be higher or more significant


          than the estimates described above.


• a $13.9 million increase in employee related costs for the nine months

ended September 30, 2022 due to an increase in headcount and resulting

wage costs of $4.3 million, a $9.6 million increase in stock compensation

expense, which includes annual refresh grants of restricted stock to

employees in the three months ended September 30, 2022 and a

one-time cumulative recognition of previously deferred stock compensation

expense of $1.6 million related to the satisfaction of the liquidity


          condition with respect to outstanding stock units recognized as a result
          of the close of the Business Combination in March 2022; and



                                       47

--------------------------------------------------------------------------------

Table of Contents

• a $6.6 million increase associated with the ongoing and expanded

investment in research and development efforts, including a $4.8 million

increase in software subscription and material costs, a $0.8 million

increase in rent and utilities, and a $1.0 million increase in

depreciation.




We expect research and development expenses to increase as we continue to invest
in the enhancement of our product offerings, including with respect to the cost
of building QPU fridges, quantum chip fabrication costs, expansion of facilities
and general salaries and wages. In addition, we have incurred, and expect to
continue to incur, increased research and development expenses due to increasing
costs of labor, including expenses associated with stock compensation in order
to attract and retain qualified personnel, including in connection with our
search for a new president and chief executive officer; equipment and component
costs impacted by the current macroeconomic environment including supply chain
constraints; and labor shortages.

Sales and Marketing Expenses



Sales and marketing increased by $1.2 million, or 151%, to $2.0 million for the
three months ended September 30, 2022, from $0.8 million for the three months
ended September 30, 2021. The increase was primarily driven by a $0.9 million
increase in stock compensation and a $0.3 million increase in consultant and
other spending on sales and development activities for the purpose of customer
growth and acquisition.

Sales and marketing increased $3.2 million, or 183%, to $4.9 million for the
nine months ended September 30, 2022, from $1.7 million for the nine months
ended September 30, 2021. The increase was primarily driven by a $0.9 million
increase in employee related costs, a $1.5 million increase in stock
compensation of which $0.4 million was related to the satisfaction of the
liquidity condition with respect to outstanding stock units recognized as a
result of the close of the Business Combination in March 2022, and a
$0.8 million increase in consultant and other spending on sales and development
activities for the purpose of customer growth and acquisition.

We expect selling and marketing expenses to increase as we seek to expand and
enhance our service offerings as well as expand our operations and customer base
globally. In addition, we anticipate implementing new marketing strategies with
respect to customer acquisition efforts and product marketing campaigns as our
technology and product offerings expand.

General and Administrative Expenses

General and administrative expenses increased by $10.6 million, or 315%, to $14.0 million for the three months ended September 30, 2022, from $3.4 million for the three months ended September 30, 2021. The increase was attributable to:

• a $1.3 million increase in legal and accounting costs related to enhanced

public reporting requirements, investor relation costs and other software


          acquisition costs;



     •    a $0.9 million increase in employee related costs as a result of

operating as a public company, including higher executive salaries and

increased headcount-related wages to build and upgrade the resources to

operate as a public company and to build out our information security


          team;



  •   a $8.0 million increase in RSU, grants, and stock compensation expense;



     •    a $0.7 million increase in other costs including directors' and officers'

insurance and other office expenses attributable to a return to in-office


          work; and



  •   a $0.1 million increase in depreciation


These costs were partially offset by the gain in change in fair value of our
Forward Warrant Agreement of $0.4 million which was entered into with Ampere as
part of our strategic collaboration agreement.

                                       48

--------------------------------------------------------------------------------

Table of Contents



General and administrative expenses increased by $29.8 million, or 346%, to
$38.4 million for the nine months ended September 30, 2022, from $8.6 million
for the nine months ended September 30, 2021. The increase was attributable to:

     •    a $25.0 million increase in stock compensation expense; which includes
          a one-time cumulative recognition of previously deferred stock
          compensation expense of $6.9 million related to the satisfaction of the

liquidity condition with respect to outstanding stock units recognized as


          a result of the closing of the Business Combination;


• a $3.7 million increase in legal and accounting costs related to enhanced

public reporting requirements, investor relation costs and other software


          acquisition costs;



     •    a $2.9 million increase in employee related costs as a result of

operating as a public company, including higher executive salaries and

increased headcount-related wages to build and upgrade the resources to

operate as a public company and to build out our information security


          team;


• One-time transaction bonuses awarded to employees in recognition of the

closing of the Business Combination and associated taxes of $1.8 million;


          and


• a $1.9 million increase in other costs including directors' and officers'


          insurance and other office expenses attributable to return to office
          work.


These costs were partially offset by the gain in change in fair value of our
Forward Warrant Agreement of $5.5 million which was entered into with Ampere as
part of our strategic collaboration agreement.

We expect general and administrative expenses to increase as we operate as a public company.



Other Income (Expense), net

Interest Expense

Interest expense was $1.4 million and $0.6 million for the three months ended
September 30, 2022 and 2021, respectively. Interest expense was $3.8 million and
$1.1 million for the nine months ended September 30, 2022 and 2021,
respectively. The increase in expense was a result of the Loan Agreement we
entered into with Trinity Capital Inc. ("Trinity") in March 2021 (as amended
from time to time, the "Loan Agreement"). The period over period increase was a
combination of the Federal Reserve increasing interest rates in response to
inflation and a longer interest period during the three and nine months ended
September 2022. For the three months and nine months ended September 30, 2022,
interest expense was based on the overall borrowings under the Loan Agreement of
$32.0 million for a three-month and nine-month interest period with higher
interest rates, while for the same period in 2021, interest expense was based on
borrowings under the Loan Agreement within a range of $12.0 to $20.0 million for
a shorter interest period of six months and 10 days based on lower interest
rates.

Interest Income



Interest income was $1.0 million and $2 thousand for the three months ended
September 30, 2022 and 2021, respectively. Interest income was $1.2 million and
$9 thousand for the nine months ended September 30, 2022 and 2021, respectively.
The increase in interest income was a result of the available-for-sales
investments we hold and the increase in interest rates on deposits due to
Federal Reserve rate increases. As of September 30, 2022, investment securities
in our Trust Account consisted of $33.0 million in money market funds,
$57.7 million in United States Treasury securities, $3.6 million in corporate
bonds and $25.9 million in commercial paper. We earned interest on such
investments. We did not hold available-for-sales investments and did not earn
interest on such investments during the three and nine months ended
September 30, 2021.

Change in Fair Value of Warrant Liabilities



A discussion of change in fair value of warranty liabilities is included in Note
10 to our unaudited condensed consolidated financial statements for the
nine-month period ended September 30, 2022, included elsewhere in this Quarterly
Report on Form 10-Q.

                                       49

--------------------------------------------------------------------------------

Table of Contents

Change in Fair Value of Earn-out Liability



A discussion of change in fair value of earn-out liability is included in Note
2, Sponsor Earn-Out Liability, to our unaudited condensed consolidated financial
statements for the nine-month period ended September 30, 2022, included
elsewhere in this Quarterly Report on Form 10-Q.

Transaction Costs



Transaction costs arose from the Business Combination allocated to
liability-classified instruments that are subsequently measured at fair value
through earnings must be expensed as incurred. We incurred total transaction
costs of $0.9 million allocated to liability-classified instruments for the
nine-month period ended September 30, 2022. We did not incur any transaction
costs for the comparable nine months ended September 30, 2021. We did not incur
any transaction costs as part of the results of operations for the three months
ended September 30, 2022 and September 30, 2021.

Liquidity and Capital Resources



We have incurred net losses since inception, and experienced negative cash flows
from operations. Prior to the Business Combination, we financed our operations
primarily through the issuance of preferred stock, warrants, convertible notes,
venture backed debt and revenues. During the nine months ended September 30,
2022, we incurred net losses of $48.6 million. As of September 30, 2022, we had
an accumulated deficit of $255.8 million, and we expect to incur additional
losses and higher operating expenses for the foreseeable future in line with our
long-term business and investment strategy. In connection with the closing of
the Business Combination on March 2, 2022, we received a total of $225.6 million
from the Business Combination and PIPE Investment, net against transaction costs
incurred by us. We believe that our existing cash and cash equivalents,
including net proceeds from the Business Combination, should be sufficient to
meet our anticipated operating cash needs for at least the next 12 months based
on our current business plan and expectations and assumptions considering
current macroeconomic conditions. We have based these estimates on assumptions
that may prove to be wrong and we could use our available capital resources
sooner than we currently expect, and future capital requirements and the
adequacy of available funds will depend on many factors, including those
described in the section titled "Risk Factors" in this Quarterly Report on Form
10-Q. Global economic conditions have been worsening, with disruptions to, and
volatility in, the credit and financial markets in the U.S. and worldwide
resulting from the effects of COVID-19 and otherwise. If these conditions
persist and deepen, we could experience an inability to access additional
capital or our liquidity could otherwise be impacted. If we are unable to raise
capital when needed or on attractive terms, we would be forced to delay, reduce
or eliminate our research and development programs and/or other efforts. A
recession or additional market corrections resulting from the impact of the
evolving effects of the COVID-19 pandemic could materially affect our business
and the value of our securities.

Our short-term cash requirements include capital expenditures for materials and
components for research and development and quantum computing fridges; working
capital requirements; and strategic collaborative arrangements and investments.

Our long-term requirements include expenditures for the planned expansion of our
quantum chip fabrication facility; planned development of multiple generations
of quantum processors; and anticipated additional investments to scale our QCaaS
offering.

We will require a significant amount of cash for expenditures as we invest in
ongoing research and development and business operations. Until such time as we
can generate significant revenue from sales of our development contracts and
other services, including our QCaaS offering, we expect to finance our cash
needs primarily through our Loan Agreement with Trinity, our arrangements with
Ampere, our committed equity financing with B. Riley, and other equity or debt
financings or other capital sources, including development contract revenue with
government agencies and strategic partnerships. To the extent that we raise
additional capital through the sale of equity or convertible debt securities,
including through the use of our committed equity financing with B. Riley, the
ownership interest of our stockholders will be, or could be, diluted, and the
terms of these securities may include liquidation or other preferences that
adversely affect the rights of our common stockholders. Debt financing and
equity financing, if available, may involve agreements that include covenants
limiting or restricting our ability to take specific actions, such as incurring
additional debt, making capital expenditures or declaring dividends. If we are
unable to raise additional funds through equity or debt financings when needed,
we may be required to delay, limit, or substantially reduce our quantum
computing development efforts. Our future capital requirements and the adequacy
of available funds will depend on many factors, including those set forth in the
section titled "Risk Factors" included in this Quarterly Report on Form 10-Q.

                                       50

--------------------------------------------------------------------------------

Table of Contents



In addition, actual sales, if any, of shares of our Common Stock to B. Riley
pursuant to the committed equity financing will depend on a variety of factors
to be determined by us from time to time, including, among other things, market
conditions, the trading price of our Common Stock and determinations by us as to
appropriate sources of funding for our business and operations. We cannot
guarantee the extent to which we may utilize the committed equity financing.

Loan and Security Agreement



On March 10, 2021, we entered into the Loan Agreement with Trinity for term
loans with a principal amount of $12.0 million, bearing an interest rate of the
greater of 7.5% plus the prime rate published by the Wall Street Journal or
11.0%. In addition, we are required to pay a final payment fee equal to 2.75% of
the aggregate amount of all term loan advances. The term loans under the Loan
Agreement are secured by all of our assets. The Loan Agreement contains
customary representations, warranties and covenants, but does not include any
financial covenants. The negative covenants include restrictions on the ability
to incur indebtedness, pay dividends, execute fundamental change transactions,
and other specified actions. In connection with entry into the Loan Agreement,
we issued a warrant to purchase our shares of Common Stock to Trinity. The
Guarantor of the loan is Rigetti Holdings, Inc. and the loan is secured by
substantially all of our assets.

On May 18, 2021, we entered into a first amendment to the Loan Agreement, which
modified certain financial covenants, including an additional good faith deposit
of $20,000 and adding a tranche B to the Loan Agreement in an aggregate amount
of $15.0 million, consisting of two advances of $8.0 million and $7.0 million
each. In connection with such amendment, the maturity date was modified to be
the date equal to 48 months from the first payment date of each specific cash
advance. In connection with such amendment, we cancelled the initial warrants
and issued a warrant to purchase 995,099 shares of our Common Stock.

On October 21, 2021, we entered into a second amendment to the Loan Agreement,
which modified the date requiring us to deliver evidence of completion of the
PIPE transaction and execution of a definitive merger agreement with a special
purpose acquisition company to October 31, 2021.

Pursuant to the second amendment, the maturity date was modified to be the date
equal to 48 months from the first payment date of each specific cash advance.
Subject to an interest only period of 18 months following each specific cash
advance date, the term loan incurs interest at the greater of a variable
interest rate based on prime rate or 11% per annum, payable monthly.
Interest-only payments are due monthly immediately following an advance for a
period of 18 months and, beginning on the 19th month, principal and interest
payments are due monthly.

In January 2022, we entered into the third amendment to the Loan Agreement to
increase the debt commitment by $5.0 million to $32.0 million. The amendment
allows us to draw an additional $5.0 million immediately with an additional
$8.0 million to be drawn at the sole discretion of the lender. We drew the
additional $5.0 million upon signing the amendment. Other modifications per the
amendment included an extension of the requirement to raise an additional
$75.0 million of equity and a defined exit fee for the additional $5.0 million
to be at 20% of the advanced funds under the amendment. In conjunction with the
amendment, we also guaranteed payment of all monetary amounts owed and
performance of all covenants, obligations and liabilities. As of September 30,
2022, the total principal amount outstanding under the Loan Agreement was
approximately $32.0 million. We use borrowings under the Loan Agreement for
working capital purposes.

The Loan Agreement is secured by a first-priority security interest in substantially all of our assets. As of the date of this Quarterly Report on Form 10-Q, we are in compliance with all covenants under the Loan Agreement.



Our cash commitments as of September 30, 2022 were primarily as follows (in
thousands):

                               Total        Short-Term       Long-Term

                                           (in thousands)
Financing obligations         $ 32,000     $      5,974     $    26,026
Operating lease obligations      9,660            1,317           8,343

Total                         $ 41,660     $      7,291     $    34,369



Financing obligations consist of payments related to the Loan and Security
Agreement. Operating lease obligations consist of obligations under
non-cancelable operating leases for our offices and facilities. The cash
requirements in the table above are associated with contracts that are
enforceable and legally binding and that specify all significant terms,
including fixed or minimum services to be used, fixed, minimum or variable price
provisions, and the approximate timing of the actions under the contracts. The
table does not include obligations under agreements that we can cancel without a
significant penalty.

                                       51

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses